FENNEC PHARMACEUTICALS INC. Operating Income
FENNEC PHARMACEUTICALS INC. (FENC) reported Operating Income of $1.74 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-13
- FENNEC PHARMACEUTICALS INC. operating income (loss) for the quarter ending 2026-06-30 was $1.74M.
- FENNEC PHARMACEUTICALS INC. operating income (loss) for the quarter ending 2026-03-31 was -$119.00K.
- FENNEC PHARMACEUTICALS INC. operating income (loss) for the quarter ending 2025-12-31 was -$2.55M.
- FENNEC PHARMACEUTICALS INC. operating income (loss) for the quarter ending 2025-09-30 was -$189.00K.
- FENNEC PHARMACEUTICALS INC. operating income (loss) for fiscal 2025 was -$6.28M, a 344.63% decline from fiscal 2024.
- FENNEC PHARMACEUTICALS INC. operating income (loss) for fiscal 2024 was $2.57M.
- FENNEC PHARMACEUTICALS INC. operating income (loss) for fiscal 2023 was -$12.77M.
- FENNEC PHARMACEUTICALS INC. operating income (loss) for fiscal 2022 was -$22.59M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month | Operating Income (Loss) 178 month | Operating Income (Loss) 181 month | Operating Income (Loss) 184 month | Operating Income (Loss) 187 month | Operating Income (Loss) 190 month | Operating Income (Loss) 193 month | Operating Income (Loss) 196 month | Operating Income (Loss) 199 month | Operating Income (Loss) 202 month | Operating Income (Loss) 205 month | Operating Income (Loss) 208 month | Operating Income (Loss) 211 month | Operating Income (Loss) 214 month | Operating Income (Loss) 217 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.74M 10-Q · filed 2026-08-13 | $1.62M 10-Q · filed 2026-08-13 | -$936.00K derived: sum of 3 quarters · filed 2026-08-13 | -$1.13M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||||
| 2026-03-31 | -$119.00K 10-Q · filed 2026-05-14 | -$2.67M derived: sum of 2 quarters · filed 2026-05-14 | -$2.86M derived: sum of 3 quarters · filed 2026-05-14 | -$5.59M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||||
| 2025-12-31 | -$2.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | -$2.74M derived: sum of 2 quarters · filed 2026-03-27 | -$5.47M derived: sum of 3 quarters · filed 2026-08-13 | -$6.28M 10-K · filed 2026-03-27 | ||||||||||||||
| 2025-09-30 | -$189.00K 10-Q · filed 2025-11-13 | -$2.92M derived: sum of 2 quarters · filed 2026-08-13 | -$3.73M 10-Q · filed 2025-11-13 | -$4.66M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||||
| 2025-06-30 | -$2.73M 10-Q · filed 2026-08-13 | -$3.54M 10-Q · filed 2026-08-13 | -$4.47M derived: sum of 3 quarters · filed 2026-08-13 | -$9.68M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||||
| 2025-03-31 | -$808.00K 10-Q · filed 2026-05-14 | -$1.74M derived: sum of 2 quarters · filed 2026-05-14 | -$6.94M derived: sum of 3 quarters · filed 2026-05-14 | -$11.98M derived: sum of 4 quarters · filed 2026-05-14 | ||||||||||||||
| 2024-12-31 | -$934.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | -$6.14M derived: sum of 2 quarters · filed 2026-03-27 | -$11.18M derived: sum of 3 quarters · filed 2026-03-27 | $2.57M 10-K · filed 2026-03-27 | ||||||||||||||
| 2024-09-30 | -$5.20M 10-Q · filed 2025-11-13 | -$10.24M derived: sum of 2 quarters · filed 2025-11-13 | $3.50M 10-Q · filed 2025-11-13 | $1.68M derived: sum of 4 quarters · filed 2025-11-13 | ||||||||||||||
| 2024-06-30 | -$5.04M 10-Q · filed 2025-08-14 | $8.70M 10-Q · filed 2025-08-14 | $6.89M derived: sum of 3 quarters · filed 2025-08-14 | $5.87M derived: sum of 4 quarters · filed 2025-08-14 | ||||||||||||||
| 2024-03-31 | $13.74M 10-Q · filed 2025-05-14 | $11.93M derived: sum of 2 quarters · filed 2025-05-14 | $10.91M derived: sum of 3 quarters · filed 2025-05-14 | $6.24M derived: sum of 4 quarters · filed 2025-05-14 | ||||||||||||||
| 2023-12-31 | -$1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | -$2.83M derived: sum of 2 quarters · filed 2025-03-26 | -$7.50M derived: sum of 3 quarters · filed 2025-03-26 | -$12.77M 10-K · filed 2025-03-26 | ||||||||||||||
| 2023-09-30 | -$1.02M 10-Q · filed 2024-11-08 | -$5.68M derived: sum of 2 quarters · filed 2024-11-08 | -$10.95M 10-Q · filed 2024-11-08 | -$17.09M derived: sum of 4 quarters · filed 2024-11-08 | ||||||||||||||
| 2023-06-30 | -$4.67M 10-Q · filed 2024-08-13 | -$9.94M 10-Q · filed 2024-08-13 | -$16.07M derived: sum of 3 quarters · filed 2024-08-13 | -$23.97M derived: sum of 4 quarters · filed 2024-08-13 | ||||||||||||||
| 2023-03-31 | -$5.27M 10-Q · filed 2024-05-14 | -$11.40M derived: sum of 2 quarters · filed 2024-05-14 | -$19.30M derived: sum of 3 quarters · filed 2024-05-14 | -$24.31M derived: sum of 4 quarters · filed 2024-05-14 | ||||||||||||||
| 2022-12-31 | -$6.13M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$14.03M derived: sum of 2 quarters · filed 2024-03-29 | -$19.04M derived: sum of 3 quarters · filed 2024-03-29 | -$22.59M 10-K · filed 2024-03-29 | ||||||||||||||
| 2022-09-30 | -$7.90M 10-Q · filed 2023-11-09 | -$12.91M derived: sum of 2 quarters · filed 2023-11-09 | -$16.45M 10-Q · filed 2023-11-09 | -$20.66M derived: sum of 4 quarters · filed 2023-11-09 | ||||||||||||||
| 2022-06-30 | -$5.01M 10-Q · filed 2023-08-07 | -$8.55M 10-Q · filed 2023-08-07 | -$12.76M derived: sum of 3 quarters · filed 2023-08-07 | -$16.93M derived: sum of 4 quarters · filed 2023-08-07 | ||||||||||||||
| 2022-03-31 | -$3.55M 10-Q · filed 2023-05-12 | -$7.75M derived: sum of 2 quarters · filed 2023-05-12 | -$11.93M derived: sum of 3 quarters · filed 2023-05-12 | -$15.85M derived: sum of 4 quarters · filed 2023-05-12 | ||||||||||||||
| 2021-12-31 | -$4.21M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | -$8.38M derived: sum of 2 quarters · filed 2023-03-29 | -$12.30M derived: sum of 3 quarters · filed 2023-03-29 | -$17.22M 10-K · filed 2023-03-29 | ||||||||||||||
| 2021-09-30 | -$4.17M 10-Q · filed 2022-11-14 | -$8.09M derived: sum of 2 quarters · filed 2022-11-14 | -$13.02M 10-Q · filed 2022-11-14 | -$16.36M derived: sum of 4 quarters · filed 2022-11-14 | ||||||||||||||
| 2021-06-30 | -$3.92M 10-Q · filed 2022-08-12 | -$8.84M 10-Q · filed 2022-08-12 | -$12.19M derived: sum of 3 quarters · filed 2022-08-12 | -$18.05M derived: sum of 4 quarters · filed 2022-08-12 | ||||||||||||||
| 2021-03-31 | -$4.92M 10-Q · filed 2022-05-12 | -$8.27M derived: sum of 2 quarters · filed 2022-05-12 | -$14.13M derived: sum of 3 quarters · filed 2022-05-12 | -$18.97M derived: sum of 4 quarters · filed 2022-05-12 | ||||||||||||||
| 2020-12-31 | -$3.35M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$9.21M derived: sum of 2 quarters · filed 2022-02-28 | -$14.05M derived: sum of 3 quarters · filed 2022-02-28 | -$17.89M 10-K · filed 2022-02-28 | ||||||||||||||
| 2020-09-30 | -$5.86M 10-Q · filed 2021-11-10 | -$10.70M derived: sum of 2 quarters · filed 2021-11-10 | -$14.54M 10-Q · filed 2021-11-10 | -$18.19M derived: sum of 4 quarters · filed 2021-11-10 | ||||||||||||||
| 2020-06-30 | -$4.84M 10-Q · filed 2021-08-10 | -$8.68M 10-Q · filed 2021-08-10 | -$12.33M derived: sum of 3 quarters · filed 2021-08-10 | -$14.20M derived: sum of 4 quarters · filed 2021-08-10 | ||||||||||||||
| 2020-03-31 | -$3.83M 10-Q · filed 2021-05-13 | -$7.49M derived: sum of 2 quarters · filed 2021-05-13 | -$9.35M derived: sum of 3 quarters · filed 2021-05-13 | -$14.16M derived: sum of 4 quarters · filed 2021-05-13 | ||||||||||||||
| 2019-12-31 | -$3.65M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | -$5.52M derived: sum of 2 quarters · filed 2021-03-30 | -$10.33M derived: sum of 3 quarters · filed 2021-03-30 | -$13.01M 10-K · filed 2021-03-30 | ||||||||||||||
| 2019-09-30 | -$1.86M 10-Q · filed 2020-11-16 | -$6.68M derived: sum of 2 quarters · filed 2020-11-16 | -$9.36M 10-Q · filed 2020-11-16 | -$12.46M derived: sum of 4 quarters · filed 2020-11-16 | ||||||||||||||
| 2019-06-30 | -$4.81M 10-Q · filed 2020-08-05 | -$7.49M 10-Q · filed 2020-08-05 | -$10.60M derived: sum of 3 quarters · filed 2020-08-05 | -$13.45M derived: sum of 4 quarters · filed 2020-08-05 | ||||||||||||||
| 2019-03-31 | -$2.68M 10-Q · filed 2020-05-14 | -$5.79M derived: sum of 2 quarters · filed 2020-05-14 | -$8.63M derived: sum of 3 quarters · filed 2020-05-14 | -$11.30M derived: sum of 4 quarters · filed 2020-05-14 | ||||||||||||||
| 2018-12-31 | -$3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | -$5.95M derived: sum of 2 quarters · filed 2020-02-14 | -$8.62M derived: sum of 3 quarters · filed 2020-02-14 | -$10.41M 10-K · filed 2020-02-14 | ||||||||||||||
| 2018-09-30 | -$2.85M 10-Q · filed 2019-11-12 | -$5.51M derived: sum of 2 quarters · filed 2019-11-12 | -$7.30M 10-Q · filed 2019-11-12 | -$9.82M derived: sum of 4 quarters · filed 2019-11-12 | ||||||||||||||
| 2018-06-30 | -$2.67M 10-Q · filed 2019-08-09 | -$4.46M 10-Q · filed 2019-08-09 | -$6.97M derived: sum of 3 quarters · filed 2019-08-09 | -$9.16M derived: sum of 4 quarters · filed 2019-08-09 | ||||||||||||||
| 2018-03-31 | -$1.79M 10-Q · filed 2019-05-10 | -$4.31M derived: sum of 2 quarters · filed 2019-05-10 | -$6.49M derived: sum of 3 quarters · filed 2019-05-10 | -$7.97M derived: sum of 4 quarters · filed 2019-05-10 | ||||||||||||||
| 2017-12-31 | -$2.52M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | -$4.70M derived: sum of 2 quarters · filed 2019-03-15 | -$6.18M derived: sum of 3 quarters · filed 2019-03-15 | -$6.95M 10-K · filed 2019-03-15 | ||||||||||||||
| 2017-09-30 | -$2.19M 10-Q · filed 2018-11-13 | -$3.67M derived: sum of 2 quarters · filed 2018-11-13 | -$4.44M 10-Q · filed 2018-11-13 | -$5.58M derived: sum of 4 quarters · filed 2018-11-13 | ||||||||||||||
| 2017-06-30 | -$1.48M 10-Q · filed 2018-08-13 | -$2.25M 10-Q · filed 2018-08-13 | -$3.40M derived: sum of 3 quarters · filed 2018-08-13 | -$3.96M derived: sum of 4 quarters · filed 2018-08-13 | ||||||||||||||
| 2017-03-31 | -$771.00K 10-Q · filed 2018-05-14 | -$1.92M derived: sum of 2 quarters · filed 2018-05-14 | -$2.48M derived: sum of 3 quarters · filed 2018-05-14 | -$3.19M derived: sum of 4 quarters · filed 2018-05-14 | ||||||||||||||
| 2016-12-31 | -$1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | -$1.71M derived: sum of 2 quarters · filed 2018-03-28 | -$2.42M derived: sum of 3 quarters · filed 2018-03-28 | -$2.87M 10-K · filed 2018-03-28 | ||||||||||||||
| 2016-09-30 | -$564.00K 10-Q · filed 2017-11-13 | -$1.27M derived: sum of 2 quarters · filed 2017-11-13 | -$1.73M 10-Q · filed 2017-11-13 | -$2.28M derived: sum of 4 quarters · filed 2017-11-13 | ||||||||||||||
| 2016-06-30 | -$707.00K 10-Q · filed 2017-08-14 | -$1.16M 10-Q · filed 2017-08-14 | -$1.71M derived: sum of 3 quarters · filed 2017-08-14 | -$2.05M derived: sum of 4 quarters · filed 2017-08-14 | ||||||||||||||
| 2016-03-31 | -$454.00K 10-Q · filed 2017-05-12 | -$1.00M derived: sum of 2 quarters · filed 2017-05-12 | -$1.34M derived: sum of 3 quarters · filed 2017-05-12 | -$1.89M derived: sum of 4 quarters · filed 2017-05-12 | ||||||||||||||
| 2015-12-31 | -$551.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-29 | -$889.00K derived: sum of 2 quarters · filed 2017-03-29 | -$1.44M derived: sum of 3 quarters · filed 2017-03-29 | -$1.89M 10-K · filed 2017-03-29 | ||||||||||||||
| 2015-09-30 | -$338.00K 10-Q · filed 2016-11-14 | -$887.00K derived: sum of 2 quarters · filed 2016-11-14 | -$1.34M 10-Q · filed 2016-11-14 | -$2.13M derived: sum of 4 quarters · filed 2016-11-14 | ||||||||||||||
| 2015-06-30 | -$549.00K 10-Q · filed 2016-08-12 | -$1.00M 10-Q · filed 2016-08-12 | -$1.79M derived: sum of 3 quarters · filed 2016-08-12 | -$2.41M derived: sum of 4 quarters · filed 2016-08-12 | ||||||||||||||
| 2015-03-31 | -$452.00K 10-Q · filed 2016-05-12 | -$1.24M derived: sum of 2 quarters · filed 2016-05-12 | -$1.86M derived: sum of 3 quarters · filed 2016-05-12 | -$2.79M derived: sum of 4 quarters · filed 2016-05-12 | ||||||||||||||
| 2014-12-31 | -$791.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | -$1.41M derived: sum of 2 quarters · filed 2016-03-28 | -$2.34M derived: sum of 3 quarters · filed 2016-03-28 | -$2.88M 10-K · filed 2016-03-28 | ||||||||||||||
| 2014-09-30 | -$619.00K 10-Q · filed 2015-11-12 | -$1.55M derived: sum of 2 quarters · filed 2015-11-12 | -$2.09M 10-Q · filed 2015-11-12 | -$2.50M derived: sum of 4 quarters · filed 2015-11-12 | -$118.26M 10-Q · filed 2014-11-13 | |||||||||||||
| 2014-06-30 | -$930.00K 10-Q · filed 2015-08-11 | -$1.47M 10-Q · filed 2015-08-11 | -$1.88M derived: sum of 3 quarters · filed 2015-08-11 | -$1.93M derived: sum of 4 quarters · filed 2015-08-11 | -$117.64M 10-Q · filed 2014-08-11 | |||||||||||||
| 2014-03-31 | -$537.00K 10-Q · filed 2015-05-15 | -$953.00K derived: sum of 2 quarters · filed 2015-05-15 | -$1.00M derived: sum of 3 quarters · filed 2015-05-15 | -$1.93M derived: sum of 4 quarters · filed 2015-05-15 | -$116.71M 10-Q · filed 2014-05-15 | |||||||||||||
| 2013-12-31 | -$416.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | -$467.00K derived: sum of 2 quarters · filed 2015-03-31 | -$1.39M derived: sum of 3 quarters · filed 2015-03-31 | -$1.93M 10-K · filed 2015-03-31 | -$116.18M 10-K · filed 2014-03-31 | |||||||||||||
| 2013-09-30 | -$51.00K 10-Q · filed 2014-11-13 | -$978.00K derived: sum of 2 quarters · filed 2014-11-13 | -$1.51M 10-Q · filed 2014-11-13 | -$2.64M derived: sum of 4 quarters · filed 2014-11-13 | -$115.76M 10-Q · filed 2013-11-18 | |||||||||||||
| 2013-06-30 | -$927.00K 10-Q · filed 2014-08-11 | -$1.46M 10-Q · filed 2014-08-11 | -$2.59M derived: sum of 3 quarters · filed 2014-08-11 | -$3.22M derived: sum of 4 quarters · filed 2014-08-11 | -$115.71M 10-Q · filed 2013-08-09 | |||||||||||||
| 2013-03-31 | -$537.00K 10-Q · filed 2014-05-15 | -$1.66M derived: sum of 2 quarters · filed 2014-05-15 | -$2.29M derived: sum of 3 quarters · filed 2014-05-15 | -$3.54M derived: sum of 4 quarters · filed 2014-05-15 | -$114.78M 10-Q · filed 2013-05-13 | |||||||||||||
| 2012-12-31 | -$1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | -$1.75M derived: sum of 2 quarters · filed 2014-03-31 | -$3.00M derived: sum of 3 quarters · filed 2014-03-31 | -$3.62M 10-K · filed 2014-03-31 | -$114.25M 10-K · filed 2013-04-01 | |||||||||||||
| 2012-09-30 | -$630.00K 10-Q · filed 2013-11-18 | -$1.88M derived: sum of 2 quarters · filed 2013-11-18 | -$2.50M 10-Q · filed 2013-11-18 | -$3.40M derived: sum of 4 quarters · filed 2013-11-18 | -$113.12M 10-Q · filed 2012-11-14 | |||||||||||||
| 2012-06-30 | -$1.25M 10-Q · filed 2013-08-09 | -$1.87M 10-Q · filed 2013-08-09 | -$2.77M derived: sum of 3 quarters · filed 2013-08-09 | -$3.71M derived: sum of 4 quarters · filed 2013-08-09 | -$112.49M 10-Q · filed 2012-08-13 | |||||||||||||
| 2012-03-31 | -$616.00K 10-Q · filed 2013-05-13 | -$1.52M derived: sum of 2 quarters · filed 2013-05-13 | -$2.46M derived: sum of 3 quarters · filed 2013-05-13 | -$3.03M derived: sum of 4 quarters · filed 2013-05-13 | -$111.24M 10-Q · filed 2012-05-15 | |||||||||||||
| 2011-12-31 | -$902.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01 | -$1.85M derived: sum of 2 quarters · filed 2013-04-01 | -$2.42M derived: sum of 3 quarters · filed 2013-04-01 | -$3.44M 10-K · filed 2013-04-01 | -$110.63M 10-K · filed 2012-03-27 | |||||||||||||
| 2011-09-30 | -$944.00K 10-Q · filed 2012-11-14 | -$1.52M derived: sum of 2 quarters · filed 2012-11-14 | -$2.54M 10-Q · filed 2012-11-14 | -$3.35M derived: sum of 4 quarters · filed 2012-11-14 | -$109.72M 10-Q · filed 2011-11-14 | |||||||||||||
| 2011-06-30 | -$572.00K 10-Q · filed 2012-08-13 | -$1.59M 10-Q · filed 2012-08-13 | -$2.41M derived: sum of 3 quarters · filed 2012-08-13 | -$3.33M derived: sum of 4 quarters · filed 2012-08-13 | -$108.78M 10-Q · filed 2011-08-15 | |||||||||||||
| 2011-03-31 | -$1.02M 10-Q · filed 2012-05-15 | -$1.84M derived: sum of 2 quarters · filed 2012-05-15 | -$2.75M derived: sum of 3 quarters · filed 2012-05-15 | -$5.26M derived: sum of 4 quarters · filed 2012-05-15 | ||||||||||||||
| 2010-12-31 | -$816.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-27 | -$1.73M derived: sum of 2 quarters · filed 2012-03-27 | -$4.24M derived: sum of 3 quarters · filed 2012-03-27 | -$4.60M 10-K · filed 2012-03-27 | ||||||||||||||
| 2010-09-30 | -$917.00K 10-Q · filed 2011-11-14 | -$3.42M derived: sum of 2 quarters · filed 2011-11-14 | -$3.79M 10-Q · filed 2011-11-14 | |||||||||||||||
| 2010-06-30 | -$2.50M 10-Q · filed 2011-08-15 | -$2.87M 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |